Ardelyx, Inc. (ARDX)
ARDX Stock Chart More Charts
ARDX Price/Volume Stats
| Current price | $3.95 |
| Prev. close | $4.25 |
| Day low | $3.90 |
| Day high | $4.30 |
| 50-day MA | $4.69 |
| 200-day MA | $5.64 |
| 52-week high | $8.65 |
| 52-week low | $3.75 |
| Volume | 1,329,200 |
| Avg. volume | 493,982 |
| Dividend yield | N/A |
| Market Cap | 188.02M |
ARDX Returns
| 1-mo | -13.19% |
| 3-mo | -28.18% |
| 6-mo | -42.34% |
| 1-year | -16.84% |
| 3-year | -75.96% |
| 5-year | N/A |
| YTD | -40.15% |
| 2017 | -53.52% |
| 2016 | -21.63% |
| 2015 | -4.08% |
| 2014 | N/A |
| 2013 | N/A |
Ardelyx, Inc. (ARDX) Company Bio
Ardelyx is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative, minimally-systemic, small molecule therapeutics that work exclusively in the gastrointestinal tract to treat cardio-renal, gastrointestinal and metabolic diseases. The company was founded in 2007 and is based in Fremont, California.
Loading social stream, please wait...